Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FC-12738 Single Ascending Dose in Health Adult and Patients With ALS

NCT05978908 is registered in ClinicalTrials.gov with Neurodegenerative Disease Research Inc as lead sponsor.

NCT NCT05978908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05978908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FC-12738 Single Ascending Dose in Health Adult and Patients With ALS
Lead sponsor
Neurodegenerative Disease Research Inc
Phase
Phase 1
Overall status
Completed
Start date
February 20, 2024
Completion date
June 28, 2024
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety issues, tolerance